JP5785075B2 - シアノフィシンジペプチドのバイオテクノロジー的製造 - Google Patents

シアノフィシンジペプチドのバイオテクノロジー的製造 Download PDF

Info

Publication number
JP5785075B2
JP5785075B2 JP2011513006A JP2011513006A JP5785075B2 JP 5785075 B2 JP5785075 B2 JP 5785075B2 JP 2011513006 A JP2011513006 A JP 2011513006A JP 2011513006 A JP2011513006 A JP 2011513006A JP 5785075 B2 JP5785075 B2 JP 5785075B2
Authority
JP
Japan
Prior art keywords
cgp
arginine
cphe
dipeptide
degradation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2011513006A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011522557A5 (https=
JP2011522557A (ja
Inventor
サラーム，アーメッド
ステインブーチェル，アレキサンダー
Original Assignee
ヴェスト フェリッシェ ウェルヘルムス ウニベルジテート ミュンスター
ヴェスト フェリッシェ ウェルヘルムス ウニベルジテート ミュンスター
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヴェスト フェリッシェ ウェルヘルムス ウニベルジテート ミュンスター, ヴェスト フェリッシェ ウェルヘルムス ウニベルジテート ミュンスター filed Critical ヴェスト フェリッシェ ウェルヘルムス ウニベルジテート ミュンスター
Publication of JP2011522557A publication Critical patent/JP2011522557A/ja
Publication of JP2011522557A5 publication Critical patent/JP2011522557A5/ja
Application granted granted Critical
Publication of JP5785075B2 publication Critical patent/JP5785075B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/485—Exopeptidases (3.4.11-3.4.19)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/15—Peptidyl-dipeptidases (3.4.15)
    • C12Y304/15006—Cyanophycinase (3.4.15.6)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Animal Husbandry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2011513006A 2008-06-13 2009-06-15 シアノフィシンジペプチドのバイオテクノロジー的製造 Active JP5785075B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08158205.8 2008-06-13
EP08158205.8A EP2133419B1 (en) 2008-06-13 2008-06-13 Uses of cyanophycin beta-dipeptides
PCT/EP2009/057382 WO2009150252A2 (en) 2008-06-13 2009-06-15 Biotechnological production of cyanophycin dipeptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015145684A Division JP6244336B2 (ja) 2008-06-13 2015-07-23 シアノフィシンジペプチドのバイオテクノロジー的製造

Publications (3)

Publication Number Publication Date
JP2011522557A JP2011522557A (ja) 2011-08-04
JP2011522557A5 JP2011522557A5 (https=) 2012-07-26
JP5785075B2 true JP5785075B2 (ja) 2015-09-24

Family

ID=39895026

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011513006A Active JP5785075B2 (ja) 2008-06-13 2009-06-15 シアノフィシンジペプチドのバイオテクノロジー的製造
JP2015145684A Active JP6244336B2 (ja) 2008-06-13 2015-07-23 シアノフィシンジペプチドのバイオテクノロジー的製造

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015145684A Active JP6244336B2 (ja) 2008-06-13 2015-07-23 シアノフィシンジペプチドのバイオテクノロジー的製造

Country Status (8)

Country Link
US (2) US8980845B2 (https=)
EP (2) EP2133419B1 (https=)
JP (2) JP5785075B2 (https=)
CN (2) CN102066559B (https=)
DK (2) DK2133419T3 (https=)
ES (2) ES2701727T3 (https=)
PL (1) PL2133419T3 (https=)
WO (1) WO2009150252A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016028024A (ja) * 2008-06-13 2016-02-25 ヴェスト フェリッシェ ウェルヘルムス ウニベルジテート ミュンスター シアノフィシンジペプチドのバイオテクノロジー的製造

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017068149A1 (en) * 2015-10-21 2017-04-27 Cysal Gmbh Aspartyl-dipeptides for aquaculture
KR102700159B1 (ko) * 2015-12-09 2024-08-30 씨제이제일제당 주식회사 반추위 보호 펩타이드 유도체 및 그 용도
WO2017162879A1 (en) * 2016-03-24 2017-09-28 Cysal Gmbh Aspartyl-dipeptides for skin care and cosmetic use
WO2017174398A1 (en) 2016-04-07 2017-10-12 Cysal Gmbh Cyanophycin for slow feeding aquatic organisms
CN107488210B (zh) * 2016-06-13 2021-03-30 首都医科大学 华法林-4-o-乙酰-二肽,其合成,活性和应用
US20210188905A1 (en) * 2018-08-01 2021-06-24 Cysal Gmbh Combining beta-dipeptides and amino acids for optimal nutritional supplementation
WO2021037383A1 (en) * 2019-08-30 2021-03-04 Symrise Ag COSMETIC USE OF β-L-ASPARTYL-L-ARGININE
CN113373077B (zh) * 2021-02-07 2023-02-07 南宁海关技术中心 一种氯霉素高效降解菌、高效降解菌剂及其应用
CN113683661B (zh) * 2021-09-01 2022-03-11 济宁医学院 一种双重响应二肽超分子聚合物及其制备方法和应用
CN115746292B (zh) * 2022-05-03 2023-12-22 湘潭大学 一种活性污泥中藻青素的提取方法
CN116948939B (zh) * 2023-09-18 2023-12-12 四川厌氧生物科技有限责任公司 一种提高粪便样本挑菌多样性的方法和培养基及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4225579A (en) 1979-02-27 1980-09-30 Israel Kleinberg Means and method for improving defenses against caries
JP3146251B2 (ja) 1993-09-10 2001-03-12 宮城化学工業株式会社 ペプチド組成物とその製造法
JP3851656B2 (ja) 1994-05-04 2006-11-29 ジェネンコア インターナショナル インコーポレーテッド 改善された界面活性剤耐性を有するリパーゼ
DE19813692A1 (de) * 1998-03-27 1999-09-30 Norddeutsche Pflanzenzucht Han Cyanophycinsynthetasegene zur Erzeugung von Cyanophycin oder Cyanophycinderivaten, und ihre Verwendung
US20040137081A1 (en) 2003-01-13 2004-07-15 Peter Rohdewald Attaining sexual wellness and health of the sexual vascular system with proanthocyanidins
AU2001283962A1 (en) * 2000-08-09 2002-02-18 Bayer Aktiengesellschaft Method for improved production of cyanophycin and the secondary products thereof
US7091001B2 (en) 2004-07-30 2006-08-15 Council Of Scientific & Industrial Research Process for the preparation of high arginine peptides
EP2133419B1 (en) * 2008-06-13 2018-09-19 Westfälische Wilhelms-Universität Münster Uses of cyanophycin beta-dipeptides
WO2017068149A1 (en) 2015-10-21 2017-04-27 Cysal Gmbh Aspartyl-dipeptides for aquaculture

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016028024A (ja) * 2008-06-13 2016-02-25 ヴェスト フェリッシェ ウェルヘルムス ウニベルジテート ミュンスター シアノフィシンジペプチドのバイオテクノロジー的製造

Also Published As

Publication number Publication date
CN103520700A (zh) 2014-01-22
US9877996B2 (en) 2018-01-30
EP2283128A2 (en) 2011-02-16
JP6244336B2 (ja) 2017-12-06
ES2619952T3 (es) 2017-06-27
EP2133419B1 (en) 2018-09-19
WO2009150252A3 (en) 2010-02-18
CN102066559B (zh) 2013-11-06
CN102066559A (zh) 2011-05-18
PL2133419T3 (pl) 2019-02-28
ES2701727T3 (es) 2019-02-25
US8980845B2 (en) 2015-03-17
JP2016028024A (ja) 2016-02-25
CN103520700B (zh) 2016-03-09
EP2283128B1 (en) 2017-01-04
DK2283128T3 (en) 2017-04-24
EP2133419A1 (en) 2009-12-16
US20150231194A1 (en) 2015-08-20
WO2009150252A2 (en) 2009-12-17
HK1193357A1 (zh) 2014-09-19
JP2011522557A (ja) 2011-08-04
DK2133419T3 (en) 2019-01-14
US20110118177A1 (en) 2011-05-19

Similar Documents

Publication Publication Date Title
JP5785075B2 (ja) シアノフィシンジペプチドのバイオテクノロジー的製造
AU2007260592B2 (en) Formulation comprising whey protein and hydrolysates for improving muscle recovery
JP4172681B2 (ja) 抗高血圧性トリペプチドを含有する産物をつくる方法
CN103221531B (zh) 具有高蛋白质水解活性的瑞士乳杆菌
Sallam et al. Dipeptides in nutrition and therapy: cyanophycin-derived dipeptides as natural alternatives and their biotechnological production
KR20100057630A (ko) 아미노산 및 펩티드 제품
KR102439500B1 (ko) 바실러스 아밀로리퀴파시엔스 ny-psh 124-1 균주 및 이를 이용한 분지쇄 아미노산 생산방법
WO2014130007A1 (en) Proteolytic compositions for rapidly and extensively degrading protein supplements
US6960451B2 (en) Proteolytic fermenter
CN112654362A (zh) 用于优化营养补充的β-二肽和氨基酸的组合
CN110506105B (zh) 新型双歧杆菌属细菌
JP2006316022A (ja) ダイエタリー製品において栄養補助剤として使用するためのγ−ポリグルタミン酸（γ−ＰＧＡ、Ｈ体）及びγ−ポリグルタメート
TWI284537B (en) Blood-viscosity reducing agent
HK1193357B (en) Biotechnological production of cyanophycin dipeptides
JP5292633B2 (ja) 腎不全予防剤
Mekonnen et al. Hydrolysis of gelatin from animal hoof using bacterial gelatinase
JP4726129B2 (ja) ビフィズス菌増殖促進ペプチド
JP2000239180A (ja) カルシウム結晶化抑制作用を有する細菌の菌体から得られるタンパク質を有効成分とするカルシウム結晶化抑制・吸収促進剤及びこれを含有してなる飲食物並びに飼料

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120607

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120607

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140218

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140515

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140522

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140616

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140619

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140623

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150106

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150403

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150630

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150723

R150 Certificate of patent or registration of utility model

Ref document number: 5785075

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250